Ryzumvi is not recommended for patients with active ocular inflammation, such as iritis
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
FDA Expands Ryzumvi Approval to Include Presbyopia
Also in
FDA Approves Ryzumvi Eye Drops for Presbyopia
5
52c7ae14
Article
FDA Expands Ryzumvi Approval to Include Presbyopia
0
5
52c7ae14
Article
FDA Approves Ryzumvi Eye Drops for Presbyopia
0